nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1A—bipolar disorder	0.82	1	CbGaD
Frovatriptan—HTR1B—telencephalic ventricle—bipolar disorder	0.011	0.203	CbGeAlD
Frovatriptan—HTR1D—telencephalic ventricle—bipolar disorder	0.0106	0.197	CbGeAlD
Frovatriptan—HTR1A—telencephalic ventricle—bipolar disorder	0.00887	0.164	CbGeAlD
Frovatriptan—CYP1A2—urine—bipolar disorder	0.00617	0.114	CbGeAlD
Frovatriptan—HTR1A—blood plasma—bipolar disorder	0.00423	0.0782	CbGeAlD
Frovatriptan—CYP1A2—blood plasma—bipolar disorder	0.00322	0.0596	CbGeAlD
Frovatriptan—HTR1B—nervous system—bipolar disorder	0.00156	0.0288	CbGeAlD
Frovatriptan—HTR1D—nervous system—bipolar disorder	0.00151	0.0279	CbGeAlD
Frovatriptan—HTR1A—nervous system—bipolar disorder	0.00126	0.0233	CbGeAlD
Frovatriptan—HTR1B—brain—bipolar disorder	0.00119	0.022	CbGeAlD
Frovatriptan—HTR1A—cerebellum—bipolar disorder	0.00118	0.0219	CbGeAlD
Frovatriptan—HTR1D—brain—bipolar disorder	0.00115	0.0213	CbGeAlD
Frovatriptan—CYP1A2—thyroid gland—bipolar disorder	0.00114	0.0211	CbGeAlD
Frovatriptan—HTR1A—brain—bipolar disorder	0.000961	0.0178	CbGeAlD
Frovatriptan—HTR1D—GPCR ligand binding—DRD3—bipolar disorder	0.000168	0.00133	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—RGS4—bipolar disorder	0.000167	0.00132	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—ADM—bipolar disorder	0.000166	0.00131	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000164	0.0013	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—DRD3—bipolar disorder	0.000164	0.0013	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000163	0.00129	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—DRD4—bipolar disorder	0.000163	0.00129	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TSHB—bipolar disorder	0.000162	0.00128	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TACR1—bipolar disorder	0.000162	0.00128	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00016	0.00126	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00016	0.00126	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—DRD4—bipolar disorder	0.00016	0.00126	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD5—bipolar disorder	0.000158	0.00125	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—RGS4—bipolar disorder	0.000155	0.00123	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD5—bipolar disorder	0.000155	0.00122	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—COMT—bipolar disorder	0.000154	0.00122	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—DRD2—bipolar disorder	0.000152	0.0012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—RGS4—bipolar disorder	0.000152	0.0012	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000149	0.00118	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—DRD2—bipolar disorder	0.000149	0.00118	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DGKH—bipolar disorder	0.000142	0.00112	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—POMC—bipolar disorder	0.00014	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00014	0.00111	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—POMC—bipolar disorder	0.000137	0.00109	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000137	0.00108	CbGpPWpGaD
Frovatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000135	0.00107	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TAC1—bipolar disorder	0.000132	0.00104	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TRPC3—bipolar disorder	0.000132	0.00104	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD5—bipolar disorder	0.00013	0.00103	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2C—bipolar disorder	0.000129	0.00102	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD1—bipolar disorder	0.000129	0.00102	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TRPC3—bipolar disorder	0.000129	0.00102	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DGKH—bipolar disorder	0.000129	0.00102	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RGS4—bipolar disorder	0.000127	0.00101	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADM—bipolar disorder	0.000126	0.000995	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD3—bipolar disorder	0.000125	0.000991	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.000124	0.000983	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADM—bipolar disorder	0.000123	0.000974	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TSHB—bipolar disorder	0.000123	0.00097	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TACR1—bipolar disorder	0.000123	0.00097	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PDE4B—bipolar disorder	0.000123	0.00097	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000122	0.000962	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD4—bipolar disorder	0.000122	0.000962	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PDE4B—bipolar disorder	0.00012	0.00095	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TSHB—bipolar disorder	0.00012	0.00095	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TACR1—bipolar disorder	0.00012	0.00095	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TRPC3—bipolar disorder	0.00012	0.000947	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD5—bipolar disorder	0.000118	0.000932	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TRPC3—bipolar disorder	0.000117	0.000928	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RGS4—bipolar disorder	0.000116	0.000914	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADM—bipolar disorder	0.000114	0.000904	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD2—bipolar disorder	0.000113	0.000896	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADM—bipolar disorder	0.000112	0.000885	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000112	0.000883	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PDE4B—bipolar disorder	0.000111	0.000881	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TSHB—bipolar disorder	0.000111	0.000881	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TACR1—bipolar disorder	0.000111	0.000881	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKR1C4—bipolar disorder	0.000111	0.000877	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00011	0.000868	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000109	0.000864	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TSHB—bipolar disorder	0.000109	0.000862	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PDE4B—bipolar disorder	0.000109	0.000862	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TACR1—bipolar disorder	0.000109	0.000862	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKR1C4—bipolar disorder	0.000109	0.000859	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000108	0.000853	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2A—bipolar disorder	0.000106	0.000842	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—POMC—bipolar disorder	0.000105	0.000828	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000104	0.000824	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2A—bipolar disorder	0.000104	0.000824	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DGKH—bipolar disorder	0.000102	0.000807	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR1A—bipolar disorder	0.000101	0.000803	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TAC1—bipolar disorder	9.99e-05	0.000791	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DGKH—bipolar disorder	9.99e-05	0.000791	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR1A—bipolar disorder	9.93e-05	0.000786	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TRPC3—bipolar disorder	9.83e-05	0.000778	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2C—bipolar disorder	9.8e-05	0.000775	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD1—bipolar disorder	9.8e-05	0.000775	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TAC1—bipolar disorder	9.78e-05	0.000774	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	9.63e-05	0.000762	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2C—bipolar disorder	9.59e-05	0.000759	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD1—bipolar disorder	9.59e-05	0.000759	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD3—bipolar disorder	9.49e-05	0.000751	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADM—bipolar disorder	9.38e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD5—bipolar disorder	9.33e-05	0.000738	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD3—bipolar disorder	9.29e-05	0.000735	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR1A—bipolar disorder	9.21e-05	0.000729	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD4—bipolar disorder	9.21e-05	0.000729	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RGS4—bipolar disorder	9.15e-05	0.000724	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PDE4B—bipolar disorder	9.14e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TSHB—bipolar disorder	9.14e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TACR1—bipolar disorder	9.14e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD5—bipolar disorder	9.14e-05	0.000723	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TAC1—bipolar disorder	9.07e-05	0.000718	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR1A—bipolar disorder	9.02e-05	0.000714	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD4—bipolar disorder	9.02e-05	0.000714	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—COMT—bipolar disorder	9.01e-05	0.000713	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RGS4—bipolar disorder	8.96e-05	0.000709	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—MAOA—bipolar disorder	8.95e-05	0.000708	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TRPC3—bipolar disorder	8.93e-05	0.000707	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2C—bipolar disorder	8.9e-05	0.000704	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD1—bipolar disorder	8.9e-05	0.000704	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—COMT—bipolar disorder	8.89e-05	0.000704	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TAC1—bipolar disorder	8.88e-05	0.000703	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2C—bipolar disorder	8.71e-05	0.000689	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD1—bipolar disorder	8.71e-05	0.000689	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADCY2—bipolar disorder	8.67e-05	0.000686	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	8.65e-05	0.000685	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD3—bipolar disorder	8.62e-05	0.000682	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD2—bipolar disorder	8.58e-05	0.000679	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADM—bipolar disorder	8.52e-05	0.000674	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—POMC—bipolar disorder	8.49e-05	0.000672	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADCY2—bipolar disorder	8.49e-05	0.000672	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD3—bipolar disorder	8.44e-05	0.000668	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD2—bipolar disorder	8.4e-05	0.000665	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD4—bipolar disorder	8.36e-05	0.000662	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.32e-05	0.000658	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—POMC—bipolar disorder	8.32e-05	0.000658	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TSHB—bipolar disorder	8.3e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TACR1—bipolar disorder	8.3e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PDE4B—bipolar disorder	8.3e-05	0.000657	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKR1C4—bipolar disorder	8.27e-05	0.000654	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD4—bipolar disorder	8.19e-05	0.000648	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2A—bipolar disorder	7.93e-05	0.000628	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADCY2—bipolar disorder	7.87e-05	0.000623	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD2—bipolar disorder	7.79e-05	0.000617	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—IMPA2—bipolar disorder	7.71e-05	0.00061	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADCY2—bipolar disorder	7.71e-05	0.00061	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD2—bipolar disorder	7.63e-05	0.000604	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DGKH—bipolar disorder	7.61e-05	0.000602	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TAC1—bipolar disorder	7.45e-05	0.00059	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD1—bipolar disorder	7.31e-05	0.000578	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2C—bipolar disorder	7.31e-05	0.000578	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD3—bipolar disorder	7.08e-05	0.00056	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TRPC3—bipolar disorder	7.07e-05	0.00056	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD5—bipolar disorder	6.96e-05	0.000551	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TRPC3—bipolar disorder	6.92e-05	0.000548	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD4—bipolar disorder	6.87e-05	0.000544	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RGS4—bipolar disorder	6.83e-05	0.00054	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TAC1—bipolar disorder	6.77e-05	0.000536	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADM—bipolar disorder	6.75e-05	0.000534	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	6.64e-05	0.000525	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	6.64e-05	0.000525	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADM—bipolar disorder	6.61e-05	0.000523	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TSHB—bipolar disorder	6.57e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TACR1—bipolar disorder	6.57e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDE4B—bipolar disorder	6.57e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	6.47e-05	0.000512	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TSHB—bipolar disorder	6.44e-05	0.000509	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDE4B—bipolar disorder	6.44e-05	0.000509	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TACR1—bipolar disorder	6.44e-05	0.000509	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	6.43e-05	0.000509	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	6.4e-05	0.000507	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—POMC—bipolar disorder	6.34e-05	0.000501	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	6.24e-05	0.000494	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—bipolar disorder	6.01e-05	0.000476	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—bipolar disorder	5.88e-05	0.000466	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	5.87e-05	0.000465	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	5.86e-05	0.000464	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—POMC—bipolar disorder	5.83e-05	0.000461	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	5.81e-05	0.00046	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—bipolar disorder	5.46e-05	0.000432	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR1A—bipolar disorder	5.44e-05	0.000431	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAC1—bipolar disorder	5.36e-05	0.000424	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—bipolar disorder	5.34e-05	0.000423	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR1A—bipolar disorder	5.33e-05	0.000422	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	5.27e-05	0.000417	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD1—bipolar disorder	5.26e-05	0.000416	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2C—bipolar disorder	5.26e-05	0.000416	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAC1—bipolar disorder	5.25e-05	0.000415	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—IMPA1—bipolar disorder	5.21e-05	0.000412	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD1—bipolar disorder	5.15e-05	0.000407	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2C—bipolar disorder	5.15e-05	0.000407	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NTRK2—bipolar disorder	5.11e-05	0.000405	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	5.09e-05	0.000403	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD3—bipolar disorder	5.09e-05	0.000403	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GSK3A—bipolar disorder	5.07e-05	0.000401	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADM—bipolar disorder	5.03e-05	0.000398	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NTRK2—bipolar disorder	5.01e-05	0.000396	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD3—bipolar disorder	4.98e-05	0.000394	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GSK3A—bipolar disorder	4.96e-05	0.000393	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD4—bipolar disorder	4.94e-05	0.000391	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	4.9e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TSHB—bipolar disorder	4.9e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TACR1—bipolar disorder	4.9e-05	0.000388	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD4—bipolar disorder	4.84e-05	0.000383	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—POMC—bipolar disorder	4.8e-05	0.00038	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—POMC—bipolar disorder	4.7e-05	0.000372	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADCY2—bipolar disorder	4.65e-05	0.000368	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TCF7L2—bipolar disorder	4.64e-05	0.000367	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD2—bipolar disorder	4.6e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADCY2—bipolar disorder	4.55e-05	0.00036	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TCF7L2—bipolar disorder	4.54e-05	0.000359	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD2—bipolar disorder	4.51e-05	0.000357	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	4.48e-05	0.000355	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NDUFV2—bipolar disorder	4.43e-05	0.000351	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—POMC—bipolar disorder	4.36e-05	0.000345	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C4—bipolar disorder	4.29e-05	0.00034	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—POMC—bipolar disorder	4.27e-05	0.000338	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NTRK1—bipolar disorder	4.17e-05	0.00033	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	4.08e-05	0.000323	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	4.07e-05	0.000322	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—S100B—bipolar disorder	4.05e-05	0.000321	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAC1—bipolar disorder	4e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—S100B—bipolar disorder	3.97e-05	0.000314	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD1—bipolar disorder	3.92e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	3.92e-05	0.00031	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NR1D1—bipolar disorder	3.85e-05	0.000305	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	3.81e-05	0.000302	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD3—bipolar disorder	3.8e-05	0.0003	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	3.78e-05	0.000299	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCAN—bipolar disorder	3.69e-05	0.000292	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD4—bipolar disorder	3.69e-05	0.000292	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC5A3—bipolar disorder	3.61e-05	0.000286	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	3.58e-05	0.000283	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NRG1—bipolar disorder	3.58e-05	0.000283	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NRG1—bipolar disorder	3.5e-05	0.000277	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	3.47e-05	0.000275	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	3.46e-05	0.000274	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD2—bipolar disorder	3.43e-05	0.000272	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—bipolar disorder	3.25e-05	0.000257	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—bipolar disorder	3.22e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	3.16e-05	0.00025	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	3.11e-05	0.000246	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S100B—bipolar disorder	3.02e-05	0.000239	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NRG1—bipolar disorder	2.67e-05	0.000211	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CLOCK—bipolar disorder	2.61e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	2.6e-05	0.000205	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—bipolar disorder	2.57e-05	0.000204	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—bipolar disorder	2.56e-05	0.000203	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TPH2—bipolar disorder	2.54e-05	0.000201	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TSHB—bipolar disorder	2.54e-05	0.000201	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNB2—bipolar disorder	2.54e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	2.54e-05	0.000201	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—bipolar disorder	2.52e-05	0.0002	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—bipolar disorder	2.51e-05	0.000198	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DPYD—bipolar disorder	2.5e-05	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	2.4e-05	0.00019	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CACNA1C—bipolar disorder	2.33e-05	0.000184	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	2.27e-05	0.000179	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	2.24e-05	0.000177	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SNAP25—bipolar disorder	2.03e-05	0.000161	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.94e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.92e-05	0.000152	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—bipolar disorder	1.91e-05	0.000151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADCY2—bipolar disorder	1.8e-05	0.000142	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COMT—bipolar disorder	1.54e-05	0.000122	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MAOA—bipolar disorder	1.53e-05	0.000121	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—bipolar disorder	1.25e-05	9.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—bipolar disorder	9.97e-06	7.89e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—bipolar disorder	9.91e-06	7.84e-05	CbGpPWpGaD
